Ascendis Pharma A/S ADR | Ownership
Companies that own Ascendis Pharma A/S ADR
OrbiMed Advisors LLC
4,413,291
10.63%
1,045,976
3.27%
06/30/2018
RA Capital Management LLC
4,240,536
10.21%
0
16.6%
06/30/2018
Fidelity Management & Research Co.
3,137,756
7.56%
-514,276
0.02%
06/30/2018
T. Rowe Price Associates, Inc.
3,099,099
7.46%
281,261
0.03%
06/30/2018
Baker Bros. Advisors LP
2,837,352
6.83%
0
1.31%
06/30/2018
venBio Select Advisor LLC
2,063,336
4.97%
0
5%
06/30/2018
Ecor1 Capital LLC
1,464,067
3.53%
-358,508
10.8%
06/30/2018
Farallon Capital Management LLC
1,457,297
3.51%
170,497
0.68%
06/30/2018
Eventide Asset Management LLC
1,387,000
3.34%
54,460
3.75%
06/30/2018
Perceptive Advisors LLC
1,072,647
2.58%
90,000
1.74%
06/30/2018
| Address |
Tuborg Boulevard 12
Hellerup CR 2900
Denmark
|
|
Employees
|
- |
| Website |
http://www.ascendispharma.com |
| Updated |
07/08/2019 |
| Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark. |
